ARK Genomic Revolution UCITS ETF Class A USD Accumulation | ARKGRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31-01-2025 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
![]() | Fonds | - | - | - | - | 14,4 |
![]() | +/-Cat | - | - | - | - | 9,0 |
![]() | +/-Idx | - | - | - | - | 8,7 |
Categorie: Aandelen Sector Farmacie & Gezondheid | ||||||
Categorie Benchmark: Morningstar Gbl Health TME ... |
Kerngegevens | ||
slotkoers 20-02-2025 | USD 5,32 | |
Rendement 1 Dag | -6,36% | |
Morningstar Categorie™ | Aandelen Sector Farmacie & Gezondheid | |
Vestigingsland | Ierland | |
Volume | 9084 | |
Beurs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE000O5M6XO1 | |
Grootte Fonds (Mil) - | - | |
Grootte Fondsklasse (Mil) 19-02-2025 | USD 8,10 | |
Lopende Kosten Factor 18-07-2024 | 0,75% |
Beleggingsdoelstelling: ARK Genomic Revolution UCITS ETF Class A USD Accumulation | ARKG |
The investment objective of the Fund is to generate long term capital growth (5 years or more). The Fund uses an active investment management strategy to achieve the Fund’s investment objective. The Fund will invest, under normal circumstances, primarily in global equity securities of companies across multiple sectors |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
- - | ||
Oprichtingsdatum 12-04-2024 |
Advertentie |
Categorie Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI World NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? ARK Genomic Revolution UCITS ETF Class A USD Accumulation | ARKG | 19-02-2025 |
|
|
Top 5 posities | Sector | % |
![]() | ![]() | 9,07 |
![]() | ![]() | 8,96 |
![]() | ![]() | 7,75 |
![]() | ![]() | 7,61 |
![]() | ![]() | 4,94 |
![]() | ||
![]() ![]() ![]() | ||
ARK Genomic Revolution UCITS ETF Class A USD Accumulation | ARKG |